Sibylle Madlener
Medizinische Universität Wien
H-index: 30
Europe-Austria
Top articles of Sibylle Madlener
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
HGG-08. COMBINATORIAL ACTIVITY OF CDK4/6-INHIBITORS AND TRAMETINIB IN PEDIATRIC HIGH-GRADE GLIOMA WITH BRAFV600E MUTATION AND HOMOZYGOUS CDKN2A DELETION | Neuro-Oncology | Lisa Mayr Leah Mager Lisa Gabler Sibylle Madlener Julia Berger | 2023/6 |
EPEN-11. CHARACTERIZATION OF THE SPATIAL ARCHITECTURE OF INTRATUMORAL CELL STATES IN PEDIATRIC HIGH-RISK EPENDYMOMA | Neuro-Oncology | Katharina Bruckner Sibylle Madlener Carlos AO Biagi Junior Lisa Gabler Daniel Senfter | 2023/6/1 |
HGG-19. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS WITH H3K27M OR PDGFRA GENOMIC ALTERATIONS | Neuro-Oncology | Maria Trissal Lisa Mayr Kallen Schwark Jenna LaBelle Seongbae Kong | 2023/6/1 |
DIPG-08. THE LANDSCAPE OF TUMOR CELL STATES AND SPATIAL ORGANIZATION IN H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA ACROSS AGE AND LOCATION | Neuro-Oncology | Ilon Liu Li Jiang Erik Samuelsson Sergio Marco Salas Alexander Beck | 2023/6/1 |
TRLS-08. EXPERIENCE WITH THE SELECTIVE FIBROBLAST GROWTH FACTOR INHIBITOR ERDAFITINIB IN THREE PEDIATRIC PATIENTS WITH CNS TUMORS | Neuro-Oncology | Natalia Stepien Lisa Mayr Cora Hedrich Maria Aliotti Lippolis Hannah Schned | 2023/6/1 |
DDDR-17. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS | Neuro-Oncology | Lisa Mayr Maria Trissal Kallen Schwark Sina Neyazi Alexander Beck | 2023/11/1 |
Clinical applicability of miR517a detection in liquid biopsies of ETMR patients | Acta Neuropathologica | Sibylle Madlener Julia Furtner Natalia Stepien Daniel Senfter Lisa Mayr | 2023/6 |
ABSTRACT CITATION ID: NOAD073. 168 HGG-19. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS WITH H3K27M OR … | NEURO-ONCOLOGY | Maria Trissal Lisa Mayr Kallen Schwark Jenna LaBelle Seongbae Kong | 2023/6 |
ATRT-07. CLINICAL APPLICABILITY OF C19MC MIRNA DETECTION IN LIQUID BIOPSIES OF ETMR PATIENTS | Neuro-Oncology | Sibylle Madlener Julia Furtner Natalia Stepien Daniel Senfter Lisa Mayr | 2023/6/1 |
Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR | Cancers | Natalia Stepien Daniel Senfter Julia Furtner Christine Haberler Christian Dorfer | 2023/4/28 |
Clinical response to the PDGFRα inhibitor avapritinib in high-grade glioma patients | Cancer Research | Lisa Mayr Maria Trissal Kallen Schwark Jenna Labelle Andrew Groves | 2023/4/4 |
HGG-05. PERTURBING GABAERGIC NEURONAL LINEAGE IN DIFFUSE HEMISPHERIC GLIOMA, H3G34-MUTANT, HIGHLIGHTS CDK6 AS A CLINICALLY ACTIONABLE TARGET | Neuro-Oncology | Ilon Liu Gustavo Alencastro Veiga Cruzeiro Lynn Bjerke Rebecca Rogers Yura Grabovska | 2023/6/1 |
ATRT-10. SINGLE-CELL TRANSCRIPTOME ANALYSIS REVEALS CELLULAR HIERARCHIES AND THERAPEUTIC VULNERABILITIES OF ETMR | Neuro-Oncology | Alexander Beck Lisa Gabler Gustavo AV Cruzeiro Sander Lambo Bernhard Englinger | 2023/6/1 |
Viral infections in pediatric brain tumor patients treated with targeted therapies | Pediatric blood & cancer | Lisa Mayr Tobias Steinmaurer Lukas Weseslindtner Sibylle Madlener Robert Strassl | 2023/1 |
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location | Nature Genetics | Ilon Liu Li Jiang Erik R Samuelsson Sergio Marco Salas Alexander Beck | 2022/12 |
The effects of apurimic/apirimidinic endonuclease 1 as a sensitizer to sorafenib in hepatocellular carcinoma | Journal of Hepatology | Mahzeiar Samadaei Daniel Senfter Sibylle Madlener Karolina Uranowska Christine Hafner | 2022/7/1 |
EPCO-21. THE SPATIAL ORGANIZATION OF H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA | Neuro-Oncology | Ilon Liu Jiang Li Erik Samuelsson Sergio Marco Salas Alexander Beck | 2022/11/1 |
HGG-50. Specific sensitivity of pediatric high-grade glioma with ATRX inactivation to PARP inhibitor combinations | Neuro-Oncology | Anna Laemmerer Dominik Kirchhofer Sibylle Madlener Daniela Loetsch-Gojo Carola N Jaunecker | 2022/6/1 |
EPEN-23. Interaction of epigenetic regulation and telomerase re-activation in high-risk ependymoma | Neuro-Oncology | Carola N Jaunecker Dominik Kirchhofer Sibylle Madlener Anna Laemmerer Lisa Gabler | 2022/6/1 |
DDDR-22. Translation of the PDGFRA/KIT inhibitor avapritinib for pediatric high-grade glioma | Neuro-oncology | Lisa Mayr Maria Trissal Kallen Schwark Jenna Labelle Seongbae Kong | 2022/11/1 |
